Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders.

• Authors: SCHIFF Eugene R.; DIENSTAG Jules L.; KARAYALCIN Selim; GRIMM Ian S.; PERILLO Roberto P.; HUSA Petr; DE MAN R.A.; GOODMANN Zachary; CONDREAY Lynn M.; CROWTHER Lynn M.; WOESSNER Mary A.; MCPHILLIPS Penny J.; BROWN Nathalien A.; AND THE INTERNATIONAL LAMIVUDINE Investigator Group
• Year of publication: 2003
• Type: Article in Periodical
• Magazine / Source: Journal of Hepatology
• MU Faculty or unit: Faculty of Medicine
• Field: Epidemiology, infectious diseases and clinical immunology